BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.

Authors: Takashi Matsushita¹ t-matsushita@med.kanazawa-u.ac.jp, Tadahiro Kobayashi¹, Kie Mizumaki¹, Miyu Kano¹, Tomoyo Sawada¹, Momoko Tennichi¹, Ai Okamura¹, Yasuhito Hamaguchi¹, Yoichiro Iwakura^2,3, Minoru Hasegawa⁴, Manabu Fujimoto⁵, Kazuhiko Takehara¹

Source: Science Advances. Jul2018, Vol. 4 Issue 7, p1-12. 12p.

Subject Terms: *TALL-1 (Protein), *FIBROSIS, *SCLERODERMA (Disease), *B cells, *SYSTEMIC scleroderma